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Aim: To assess the contribution of MRI and proton spectroscopy (1HMRS) 
in establishing an etiological diagnosis in children with developmental 
delay (DD) and to assess whether the chance of finding specific 
abnormalities correlates with the presence of neurological signs and/or 
abnormal head circumference (HC). 
Methods: Patients were derived from a cohort of 325 consecutive 
patients with DD receiving structured multidisciplinary evaluation in our 
centre. Patients had MRI/1HMRS if a diagnosis could not be made clinically 
and if additional neurological signs and/or abnormal HC and/or an IQ 
below 50 were present. The MRI protocol consisted of axial IR, T2, FLAIR, 
sagittal T1 and coronal T2 sequences. Multivoxel 1HMRS was located in a 
plane superior to the lateral ventricles with voxels in both grey matter and 
white matter. 
Results: One hundred and nine children were scanned, 80 of them 
because of neurological signs and/or abnormal HC. Although minor 
abnormalities were noted in the vast majority of patients, MRI and/or 
1HMRS really contributed to an etiological diagnosis in only 10 (9%) 
patients, all of whom were scanned because of neurological signs. In 
these 10 patients, 1HMRS was diagnostic in one patient and of additional 
value to MRI findings in 3 patients. 
Conclusions: MRI and 1HMRS may contribute to the diagnostic 
evaluation of DD, especially if applied specifically to patients with 









Developmental delay (DD), evolving into mental retardation, is a frequent 
condition with an estimated prevalence of 1–3%.1 Physicians are to 
provide optimal care, including establishing an etiologic diagnosis. 
Determining the etiology of DD is a challenging task, which is of utmost 
importance for several reasons. First, sometimes, it may facilitate causal 
treatment and secondary prevention, thus improving clinical outcome. 
Second, it provides parents with an explanation for the abnormal 
development of their child. Third, it may indicate some landmarks for the 
prognosis. Fourth, a definite etiological diagnosis is an optimal starting 
point for genetic counselling and determining the recurrence risk in the 
family.6, 39 
Mainstay in the diagnostic evaluation is a thorough clinical history, family 
history and physical examination leading to a differential diagnosis. 
Subsequent additional investigations are important either to confirm or 
reject the clinical diagnosis, or to provide additional diagnostic clues. 
MRI of the brain is a diagnostic tool, which has been evaluated rather 
extensively with respect to DD.40-47 Abnormalities are frequently seen on 
MRI. This forms the basis for regarding it indicated in many patients.3, 10, 
48 In most studies it does not become clear whether abnormalities found 
on cerebral MRI contributed to the establishment of a diagnosis, deserving 
the label ‘etiologic’.6 
Only a few studies have described the results of cerebral 1HMRS in 
cohorts of patients with DD, comparing metabolite levels of patients with 
those of controls. Patient groups mostly consisted of patients without a 
diagnosis and with a structurally normal brain.49-52 
The goal of our study is twofold. First, to report the general MRI and 
1HMRS results in a cohort of 109 patients who underwent combined MRI 
and 1HMRS of the brain as part of a multidisciplinary, structured, 
diagnostic evaluation. Second, to examine within this cohort to what 
extent 1HMRS and MRI of the brain contributes to the process of 
establishing an etiological diagnosis in DD, and whether this contribution 
is associated with the presence of significant elementary neurological 
signs, such as abnormal head circumference (HC) or other specific 





Patients were derived from our multidisciplinary outpatient clinic for 
etiologic diagnostic evaluation of DD. Our university medical centre serves 
as a tertiary centre for the northern part of the Netherlands, but also 
receives secondary and primary referrals from the region in which it is 
located. 
All patients with a significant DD (≤2 SD or IQ ≤70) underwent a 
structured evaluation, which is described in short. Patients were initially 
seen by the coordinating physician (KTV). A first differential diagnosis was 
made the basis of clinical history, family history, observation and physical 
examination. On this basis in combination with logistical considerations, a 
diagnostic program was scheduled. 
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Multidisciplinary evaluation by a clinical geneticist, paediatric neurologist, 
paediatrician for metabolic diseases and ophthalmologist was planned and 
usually additional investigations were initiated. Without any clues for a 
specific diagnosis, these investigations basically consisted of high banding 
karyotype, FISH 22q11.2, molecular cytogenetic studies of the 
subtelomeric regions (since 2005), fragile-X analysis, blood smear, routine 
chemistry and metabolic screening of plasma (amino acids, screening for 
N-glycosylation, peroxisomal, cholesterol biosynthesis, creatine (Cr) 
metabolism disorders) and urine (amino acids, organic acids, and 
screening for purine metabolismdefects, oligosaccharidoses, 
mucopolysaccharidoses, and Cr metabolism defects). 
MRI of the brain was planned in case of: (a) presence of additional 
neurological signs; (b) abnormal HC defined as microcephaly (HC ≤ -2 
SD), macrocephaly (HC ≥ +2 SD), or clearly declining or accelerating 
head growth; and (c) specific diagnostic considerations prompting 
neuroimaging such as stigmata of a neurocutaneous disease, suspicion of 
a neurometabolic disorder based on clinical features or abnormal 
laboratory results. In addition MRI was also planned in patients with a 
more severe delay, e.g. IQ ≤ 50 or developmental age less than half of 
chronological age. When a patient fulfilled these criteria for MRI, but the 
etiology was already evident clinically, MRI was not performed (e.g. in 
children with Angelman syndrome, Cohen syndrome, velocardiofacial 
syndrome or neurofibromatosis). Results of investigations possibly 
yielding an etiological diagnosis (e.g. cytogenetic investigations) were 
awaited before performing MRI, but to avoid a delay in the diagnostic 
evaluation as a whole it was sometimes done simultaneously. 
In the period October 2002 - May 2006 a total of 325 patients made a first 
visit to our centre. The files of the patients were reviewed for overall 
results of the diagnostic evaluation in November 2007. Virtually all cases 
had been concluded at that time. One hundred and thirty seven patients 
underwent MRI, of whom 109 also underwent 1HMRS in the same session. 
Most of the 28 patients who did not have MRS were scanned before spring 
2004, when 1HMRS was not routinely incorporated in the scanning 
protocol. Of the 188 patients who were not scanned, 49 had cerebral MRI 
before referral. The 109 patients with combined MRI and 1HMRS form the 
subject of this study. 
Patients were divided in subgroups in analogy with the criteria employed 
for MRI. The first group (group A) consisted of the patients who 
underwent neuroimaging because of additional neurological signs and/or 
abnormal HC and/or specific reasons for MRI/1HMRS. The second group 
(group B) consisted of the patients who were scanned only because of a 
low level of functioning. Patient selection and study group subdivision is 
illustrated by the flow diagram in Figure 3.1. 
 
A standard birdcage head coil of a Magnetom Sonata system (Siemens 
AG, Erlangen, Germany) was used for MRI and 1HMRS at 1.5 Tesla. 
MRI: the protocol consisted of axial IR, T2, FLAIR, sagittal T1 and coronal 
T2 sequences. All MRI’s were reviewed by an experienced paediatric 
neuroradiologist (LCM) who was blinded for the specific clinical features of 
the patients beside the presence of DD. 
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Point resolved spectroscopy 2D-chemical shift imaging (CSI) 
measurements with a repetition time (TR) of 1500 ms and an echo time of 
135 ms were performed.53 An axial MRI series was used as guidance for 
defining a volume of interest for the CSI located cranial to the ventricles 
(Figure 3.2). This 2 cm thick volume was positioned in the frontoparietal 
part of the brain where the white matter is most abundant. The CSI 
defined volume of interest was maximally 8 x 8 cm2 subdivided in up to 
64 equal voxels of 2 cm3. The number of peaks fitted included the 
chemical shift ranges restricted to 3.1-3.3 ppm for choline (Cho), 2.9-3.1 
for Cr, 2.2-2.4 for glutamine/glutamate (Glx), and 1.9-2.1 for N-
acetylaspartate (NAA). Their line widths and peak intensities were 
unrestricted. Using standard post processing protocols, the raw data were 
thus processed automatically, allowing for operator independent 
quantification. Additionally, we checked manually for the presence of 
lactate at 1.3 ppm. Of the total number of maximally 64 CSI voxels the 
inner 36 were analyzed and separated into GM and WM voxels as 
described elsewhere.54 The 12 voxels lining the interhemispherical fissure 
contained grey matter, though partial volume due to a small portion of 
white matter cannot be excluded. The 12 anterior and 24 posterior voxels 
were designated frontal and parietal, respectively. 
To limit patient examination times, absolute quantification requiring 
additional CSI measurements without water suppression was not an 
option. To facilitate tissue signal comparisons, we expressed the GM and 
WM metabolite levels as percentage of the summed peak areas of Cho, Cr, 
NAA and Glx of the 36 analyzed voxels, using the following procedure: 
summing the peak areas of Cho, Cr, NAA and Glx in each brain region; 
summing these totals weighting the area of each brain region (frontal WM 
8x, frontal GM 4x, parietal WM 16x, Parietal GM 8x); dividing this figure 
by 36 yielding the average peak area in the 36 voxels; calculating the 
respective metabolite levels in a given brain region as percentage of this 
average peak area. 
Adequate age matched control metabolite levels are not available in our 
centre, especially controls less than 4 years of age are virtually lacking. 
Because of this, results are qualitative rather than quantitative. However, 
plotting the data of all patients yields a frame of reference to some degree 
(Figure 3.3). 
 
MRI and 1HMRS results were labelled as contributing to the diagnosis in 
cases where results directly suggested the correct diagnosis, or where the 
results aided in focussing subsequent investigations, eventually leading to 





Some patient characteristics - including gender, age at first visit, severity 
and type of the delay, presence of neurological signs and HC - of the 
study population (n = 109) and of the patients from the clinical population 
not included (n = 216), are listed in Table 3.1. From the study population 
80 patients were assigned to group A and 29 patients were assigned to 
group B (Figure 3.1). 
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The results of MRI and 1HMRS are summarized in Table 3.2. More detailed 
information on the clinical features and neuroimaging findings of every 
individual patient is available as electronically available data 
(supplemental Table 3.1). 
Abnormalities in structural MRI were frequently seen in both groups. At 
least one abnormality was seen in 70 (88%) of the 80 patients scanned 
with a specific indication (group A) and in 24 (83%) of the 29 patients 
scanned only because of low level of functioning (group B). The findings 
are listed in Table 3.2. 
Looking at the specific items examined, it appears that abnormalities of 
the WM, abnormal appearance of the cerebellum and 1HMRS 
abnormalities are more prevalent in group A than in group B. 
The WM showed abnormalities in 26% and 10% of patients of group A and 
B, respectively. Most often this concerned diffusely elevated signal 
intensity (Figures 3.4 and 3.7). 
The cerebellum showed abnormalities in 30% and 10% of patients, 
respectively. Volume abnormalities, suggesting hypoplasia or atrophy 
were most frequent, but a dysplastic appearance also occurred in a 
significant number of patients. 
Abnormal morphological appearance of the hippocampus and collateral 
sulcus regions was found in a relatively high number of patients in both 
group A and group B (Figure 3.8). 
Especially in the younger patients there was an increase of NAA and 
decrease of Cho with advancing age up to about 7 years (Figure 3.3). 
1HMRS abnormalities were noted in eleven patients in group A, and in one 
patient in group B. Abnormalities were the presence of lactate (Figure 
3.4); severely low Cr; elevated Cho; NAA decrease; mild Cr decrease; and 
decrease of all metabolites (except lactate). Only the elevated lactate and 
the severely deficient Cr were helpful in the diagnosis. 
An etiological diagnosis was made in 19 of the 109 (17%) patients, all in 
group A. MRI and 1HMRS contributed to these diagnoses in a total of 10 
patients (MRI and 1HMRS together in three patients, MRI alone in six 
patients and 1HMRS alone in one patient). 
The results of the 10 patients in whom MRI and/or 1HMRS contributed to 
the diagnosis are described in more detail. 
Five patients were diagnosed with a mitochondrial disorder. They were 
scanned because of respectively: (a) epilepsy and hypoventilation; (b) 
intractable epilepsy, severe hypotonia and virtually absent psychomotor 
development (Figure 3.4); (c) recurrent febrile status epilepticus and 
pyramidal tract signs; (d) ataxia and hypotonia; and (e) myoclonic 
epilepsy. Four of these five patients had prominent CSF spaces, three had 
abnormal signal intensity of the WM, one had clear atrophy of pons and 
cerebellum and two had mild cerebellar atrophy. 1HMRS showed clearly 
elevated lactate levels in all voxels in three of the five patients. In one 
patient, the elevated lactate was accompanied by decreased levels of all 
metabolites (together with the abnormal aspect of the WM suggesting the 
presence of oedema) and elevated frontal WM Cho in another patient (also 
with abnormal WM aspect on conventional MRI). 
One patient was diagnosed with guanidinoacetate methyltransferase 
(GAMT) deficiency. He was scanned because of clinically severe expressive 
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language delay, suggesting possible cerebral Cr deficiency.18, 55 1HMRS 
was diagnostic, while MRI was completely normal. 
One patient was diagnosed with Joubert syndrome based on the typical 
neuroanatomical aberrations, including molar tooth sign, batwing 
configuration of the fourth ventricle and split vermis (Figure 3.5). He was 
scanned because of hypotonia, ataxia and oculomotor abnormality (Duane 
syndrome type I), but lacked the classical neonatal signs of this diagnosis. 
Two patients were diagnosed with static encephalopathy due to perinatal 
asphyxia. The first patient was scanned because of relatively severe 
expressive language difficulties, drooling and a history of neonatal 
convulsions. The second patient was scanned because of microcephaly, 
severe choreoathetoid and spastic tetraplegia, epilepsy and severe mental 
retardation (Figure 3.6). 
One patient was diagnosed with congenital infection based on white 
matter lesions in combination with a history of pre- and dysmaturity, 
neonatal signs of infection and hypoglycemia, absence of dysmorphic 
features, and placental histopathology of (viral) chorionvillitis. 
Of the other nine patients receiving an etiological diagnosis eight had a 
chromosomal imbalance, six of them submicroscopic. 
The ninth patient was eventually diagnosed with thyroid hormone 
transporter (MCT8) deficiency.20 He had an abnormal aspect of theWM, 
elevated Cho and decreased NAA. At present this may bring attention to 






The results indicate that in our cohort of patients with DD structural MRI 
of the brain yields abnormalities in up to more than 80% of scanned 
patients, 1HMRS in about 10%. Combined MRI and 1HMRS contributes to 
a diagnosis in a much smaller, but still considerable number of patients 
(9%). 1HMRS may be of diagnostic value in specific cases with highly 
distinctive metabolite patterns, or may otherwise have an additional value 
to structural MRI. 
Our data are in keeping with those from the literature suggesting that 
neuroanatomical abnormalities are very prevalent in patients with DD. 
Several findings deserve further discussion. 
Diffusely increased white matter signal intensity on FLAIR images was 
found rather frequently (Figure 3.7). This finding should be differentiated 
from a delayed myelination, which was recently shown to be very difficult 
to ascertain.46 The significance of abnormal appearing white matter signal 
intensity is so far aspecific, occurring in different diseases. In our cohort it 
was seen in one patient with thyroid hormone transporter defect (at 4 
years of age, while scanning at 8 months of age only showed clearly 
delayed myelination), and in three of the patients with a mitochondrial 
respiratory chain defect. Furthermore, it was seen in several patients, 
apparently suffering from different conditions, but in whom no etiological 
diagnosis could be made. 
Abnormal morphological appearance of the hippocampus and 
parahippocampal sulcus regions (Figure 3.8) was found in about 30% of 
Chapter 3 
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the patients in both group A and B. This has not previously been clearly 
described in the literature on neuroimaging in DD, though it was reported 
in a case of familial duplication of 15q.57 It also has been noted that the 
hippocampus is abnormally shaped in autistic disorders, especially when 
accompanied by mental retardation.58 These abnormalities thus seem to 
reflect subtle abnormalities in the focal development of the brain. The 
hippocampus seems to fail to grow into its normal medial and horizontal 
position. Furthermore, collateral sulcus extends more cranially than 
normal. These two items result in an abnormal ‘flying seagull’ 
configuration of the temporal horn of the lateral ventricle. Most often this 
is bilateral, but an asymmetry is often noted with more pronounced 
abnormalities on the left side. It was found in several patients who were 
later diagnosed with a cytogenetic disorder. 
The age dependent trend of NAA and Cho levels we found (Figure 3.3) is 
well known in the literature.59, 60 Due to the lack of a sufficient number of 
age matched controls we cannot judge whether the metabolite levels in 
our population significantly differ from normal. 
MRI and/or 1HMRS only contributed to a diagnosis in patients from group 
A: in 10 out of 80 patients (13%). Further inspection of the data shows 
that the diagnostic yield of MRI/ 1HMRS derives purely from the patients 
with clear neurological signs or a specific reason for neuroimaging (n=69). 
MRI/1HMRS never helped establishing a diagnosis in the patients scanned 
only because of abnormal HC (n=11). These data, though the number of 
patients is relatively small, indicate that a diagnostic contribution of 
MRI/1HMRS strongly correlates with the presence of neurological signs, 
but not with isolated abnormal HC. 
For clinical practice, the data imply that performing MRI/1HMRS in DD 
certainly may contribute to the diagnostic process, but that expectations 
should not be set too high. With respect to the relevance of establishing 
an etiological diagnosis – treatment, secondary prevention, genetic 
counselling – MRI/1HMRS can mainly be used to acquire additional clues, 
necessary to make a diagnosis at the most basic level. 
Performing 1HMRS in addition to MRI in our population had a diagnostic 
value in four out of the 10 patients in whom MRI/1HMRS contributed to 
the diagnosis (5% of patients in group A), being diagnostic in one patient. 
These four 1HMRS findings were felt to be powerful indicators for the 
necessary subsequent investigations, although it cannot be excluded that 
these four diagnoses eventually would have been made if 1HMRS would 
not have been available. 
Because of the relatively small contribution to the diagnostic process as a 
whole, and because of the required general anaesthesia, MRI/1HMRS 
should only be scheduled after careful evaluation of the expected benefits 
in view of the diagnostic process as a whole. 
For instance, in a child with multiple dysmorphic features it may be 
sensible to await the results of cytogenetic investigations, which may yield 
a direct diagnosis, even in the presence of overt neurological signs or 
abnormal HC. 
On the other hand, when a patient is suspected to have a mitochondrial 
respiratory chain disorder on clinical grounds, MRI/1HMRS of the brain, 
along with biochemical evaluation may be very important as a first step to 
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further assess the probability of such a condition, before embarking on 
muscle biopsy.61 
The cost of MR studies under general anaesthesia should be considered, 
both in terms of financial resources and of risk of (mainly respiratory) 
complications. The addition of 1HMRS to the scanning protocol elongates 
anaesthesia time approximately 10 min, resulting in a total anaesthesia 
time of 50 min. There is no evidence of increasing prevalence of 
complications due to this elongation.62-65 
We suggest performing MRI/1HMRS only after careful, integral, 
multidisciplinary clinical evaluation. The chance of finding relevant, 






MRI and 1HMRS of the brain did contribute to the process of establishing 
an etiological diagnosis in DD in 9% of the patients who were scanned in 
our cohort. The primary role of MRI/1HMRS is the possible yield of 
additional diagnostic clues for the diagnosis. The chance of finding such 
clues increases when MRI/1HMRS is applied in patients selected because 
of additional elementary neurological features or those with a differential 
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Figure 3.2 Position of 1HMRS. 
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Figure 3.3 Semi quantitative 1HMRS results for NAA and Cho. Left to 
right: frontal WM, frontal GM. Upper row: NAA. Lower row: Cho. Trends of 













Figure 3.5 Transversal T2 weighted images of the patient with Joubert 
syndrome. The left panel shows the molar tooth sign, with elongated, 
vertically oriented superior cerebellar peduncles (large arrow) and deep 
interpeduncular fossa. The middle detail shows the split vermis cerebelli. 
The right detail shows the batwing configuration of the fourth ventricle. 
Figure 3.4 Patient with mitochondrial respiratory chain defect, complex I 
deficiency. Left panel: Transversal FLAIR, showing increased signal 
intensity of the WM with resulting decreased demarcation between GM 
and WM. Right panel: 1HMRS spectrum of a 1 x 1 x 2 cm voxel located in 
the parietal white matter (location indicated in right upper detail), showing 
abnormal presence a lactate at 1.3 ppm (arrow). 













Figure 3.7 Left panel: patient (8 years of age) with mild cognitive 
impairment, delayed visual maturation and slight pyramidal features at 
the legs. Transversal FLAIR, showing increased WM signal intensity and 
decreased WM – GM demarcation. IR sequences showed 
decreasedWMsignal intensity. 1HMRS was normal. Right panel: normal 
transversal FLAIR in a normally developing person (7 years of age). 
Figure 3.6 Patient diagnosed with perinatal asphyxia. Left panel: (near) 
mid sagittal T1, showing very thin corpus callosum, especially the dorsal 
part of the corpus, apparently due to loss of crossing fibres. Right panel: 
Transversal FLAIR, showing atrophy and abnormal intensity in the 
thalamus bilaterally The patient also had extensive signal intensity 






Figure3.8 Left panel: patient moderate severe developmental delay 
without additional neurological signs. Abnormal appearance of the 
hippocampi which have a medial position with the collateral sulcus 
extending far cranially, giving rise to a ‘flying seagull’ configuration of the 
temporal horns of the lateral ventricles. Detail: magnification and 
schematic indication of the ‘flying seagull’. Right panel for comparison: 
normal appearance of the hippocampi. 
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Table 3.1 Patient characteristics of the patients included (MRI + 1HMRS) 
versus the patients from the clinical population not included in the study. 
 MRI + 1HMRS No 1HMRS 
 n (%) n (%) 
MRI + 1HMRS 109 (100) 0 (0) 
MRI   28 (13) 
No MRI, but MRI before 
referral 
  49 (23) 
     
Gender     
   male 78 (72) 138 (64) 
   female 31 (28) 78 (36) 
     
Age (yr, mean, SD, range) 5,3 ± 4,1 (0,6-22) 6,9 ± 5,8 (0,2-47) 
     
Severity     
   normal 1 (1) 10 (5) 
   borderline 5 (5) 29 (13) 
   mild 36 (33) 108 (50) 
   severe 67 (61) 69 (32) 
     
Type     
   global 91 (83) 184 (85) 
   global accent language 8 (7) 12 (6) 
   global accent motor 8 (7) 11 (5) 
   global accent behaviour 1 (1) 4 (2) 
   language 1 (1) 1 (0) 
   motor 0 (0) 4 (2) 
     
Head circumference     
   normal 84 (77) 184 (85) 
   microcephaly 10 (9) 15 (7) 
   macrocephaly 8 (7) 4 (2) 
   accel. head growth 4 (4) 10 (5) 
   accel. head growth 3 (3) 3 (1) 
     
Neurological signs present 55 (50) 54 (25) 
     
Certain etiologic diagn 19 (17) 43 (20) 
     
Neuroimaging diagn eci 1 (1) 3 (1) 
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Table 3.2 Summarized results of MRI and 1HMRS. 




Abnormalities n  (%) n % 
Central CSF total 42  (53) 10 (34) 
Lateral ventricles 24  6  
Asymmetry lateral ventricles 11  0  
3d ventricle 22  4  
4th ventricle 15  1  
Peripheral CSF total 25 (31) 4 (14) 
Supratentorial 17  4  
Mega Cisterna Magna 9  0  
Brain genesis total 31 (39) 8 (28) 
Cavum septum pellucidum (et vergae) 5  0  
Abnormal aspect hippocampal / 
parahippocampal region 
26  8  
Size discrepancy (small) frontal and or 
temporal lobes 
4  0  
Asymmetry hemispheral size 1  0  
Decreased volume of the white matter 2  0  
Gyrus / sulcus pattern 2  0  
Unclassified 1  0  
Supependymal heteropia 1  0  
Gray matter total 1 (1) 1 (3) 
Abnormal signal intensity insular cortex   1  
Localised dysplasia 1  0  
White matter total 21 (26) 3 (10) 
Diffuse increased (FLAIR) signal 
intensity 
11  2  
Myelination delay 2  0  
Localised abnormalities 7  1  
Accentuated terminal zones 2  0  
Corpus callosum total 22 (28) 10 (34) 
Thin global 6  1  
Thin localised 9  6  
Dysplastic 4  2  
Thick 5  2  
Basal ganglia total 5 (6) 0 (0) 
Abnormal signal intensity 3  0  
Abnormal shape / size 3  0  
Cerebellum total 24 (30) 3 (10) 
Hypoplasia / atrophy 18  2  
Abnormal shape, including Chiari 1 6  1  
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Table 3.2, continued Summarized results of MRI and 1HMRS. 
 Group A n=80 Group B n=29 
Abnormalities n  (%) n % 
Brainstem total 8 (10) 0 (0) 
Abnormal signal intensity 2  0  
Abnormal shape / size 6  0  
Miscellaneous total 25 (31) 10 (34) 
Skull bones abnormalities 1  0  
Oedema 1  0  
Prominent perivascular spaces 21  9  
Vascular aberration 4  0  
Arachnoidal cyst 0  1  
Pineal cyst 1  0  
1HMRS total 11 (14) 1 (3) 
Lactate elevated 3  0  
Choline elevated 9  1  
Choline decreased 1  0  
Creatine deficiency (GAA present) 1  0  
Cr decrease (mild) 1  0  
NAA decrease 3  0  
MRI contributing to diagnosis 9 (11) 0 (0) 
1HMRS contributing to diagnosis 4 (5) 0 (0) 
MRI and/or 1HMRS contributing 
to diagnosis 
10 (13) 0 (0) 
Group A consists of the patients scanned because of neurological signs 
and/or abnormal HC and/or a specific indication for MRI/1HMRS. Group B 
consists of the patients scanned because of low level of functioning only. 
Rows indicate brain structures and/or loci which were scored to be normal 
or abnormal. Numbers and percentages represent the number of patients 
with the respective MRI and 1HMRS abnormalities. Detailed information 
for every individual patient can be found in supplemental table 3.1. 
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Supplemental table 3.1 
Electronically available from European Journal of Paediatric 
Neurology, or from Krijn T. Verbruggen 
 
 
 
